美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,329.27

-12.5123-0.93%

涨家数：5

跌家数：15

平家数：- -

市盈率：- -

高：1,347.58

开：1,341.87

低：1,324.07

收：1,341.78

数据加载中...

Aethlon Medical, Inc.盘中异动股价大跌5.01%

雷克兰医疗工业盘中异动急速跳水5.10%报14.79美元

Biontech Se涨1.26% 股价突破100美元大关

伊诺维奥制药盘中异动早盘股价大涨5.17%

Ibio, Inc.盘中异动股价大跌5.03%

莫德纳盘中异动早盘股价大跌5.04%报23.47美元

吉利德科学(GILD.O)宣布Trodelvy（戈沙妥珠单抗）联合Keytruda（帕博利珠单抗）在第三级临床试验中达到

古根海姆：将强生(JNJ.N)目标价从166美元下调至164美元。

十年来首个，第一三共/阿斯利康“德曲妥珠单抗”III期中期分析取得积极结果

已提交现货ETF申请的山寨币均为“美国币”或属于WLFI投资组合

Aptos社区提案拟将质押年化收益下调近50%以提升资本效率

近90%患者缓解的强生口服多肽疗法；默沙东达近5亿美元口服多肽疗法合作 TIDES周报

Aptos社区发起“分阶段降低质押奖励率”提案

阿斯利康(AZN.US)乳腺癌1类创新药在中国获批

辉瑞：已计入风险，买入具有卓越估值和收益的股票

美股研究社

【沃森生物：20价肺炎球菌多糖结合疫苗获临床试验批准】沃森生物公告，公司及子公司共同申请的20价肺炎球菌多糖结合疫苗获得国家药品监督管理局签发的《药物临床试验批准通知书》，通知书编号为2025LP01099。该疫苗是在已上市产品13价肺炎球菌多糖结合疫苗基础上开发的迭代升级产品，新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共计7种血清型，用于预防由本品所含20种肺炎球菌血清型引起的感染性疾病。全球已上市20价肺炎球菌多糖结合疫苗的厂家仅有美国辉瑞公司一家，国内尚未有20价肺炎球菌多糖结合疫苗上市销售。

辉瑞4月17日成交额为12.06亿美元

强生心血管业务发力了

莫德纳4月17日成交额为1.65亿美元

强生4月17日成交额为17.30亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1329.2725,"timestamp":1745263685387,"preClose":1341.7848,"halted":0,"volume":50739602,"delay":0,"changeRate":-0.009325,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-12.512329,"latestTime":"04-21 15:28:05 EDT","open":1341.8679,"high":1347.5837,"low":1324.0696,"amount":2355960271.047674,"amplitude":0.017525,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745265600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.634027,"peRate":24.10889,"turnoverRate":0.00327,"increases":5,"decrements":15,"flats":0,"marketCap":1098080883498,"floatMarketCap":1078801595571.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1347.5837,"amplitude":0.017525,"preClose":1341.7848,"low":1324.0696,"pbRate":"3.634027","latestPrice":1329.2725,"volume":50739402,"delay":0,"open":1341.8679,"prevYearClose":1274.8187,"prevWeekClose":1341.7848,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1308.2719,"twentyDayClose":1415.9906,"sixtyDayClose":1315.7013,"secType":"PLATE","market":"US","turnoverRate":0.00327,"peRate":24.10889,"marketCap":1098080883498,"floatMarketCap":1078801595571.5,"timestamp":1745263685205,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529391003","title":"Aethlon Medical, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529391003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529391003?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 23:41","pubTimestamp":1745250073,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时41分，Aethlon Medical, Inc.股票出现异动，股价大幅跳水5.01%。截至发稿，该股报0.341美元/股，成交量1.5103万股，换手率0.07%，振幅4.65%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体跌幅为1.59%。其相关个股中，Reshape Lifesciences, Inc.、Electrocore, Inc.、Anteris Technologies Global Corp.涨幅较大，Reshape Lifesciences, Inc.、Adagio Medical Holdings, Inc、Nanovibronix, Inc.较为活跃，换手率分别为1076.28%、10.31%、6.33%，振幅较大的相关个股有Dih Holdings Us Inc C/Wts 20/04/2028 、Reshape Lifesciences, Inc.、Tenon Medical Inc C/Wts 16/06/2028 ，振幅分别为70.20%、38.81%、35.89%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421234113a4613f77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421234113a4613f77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","AEMD","BK4082","BK4568"],"gpt_icon":0},{"id":"2529381287","title":"雷克兰医疗工业盘中异动 急速跳水5.10%报14.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529381287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529381287?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 23:07","pubTimestamp":1745248063,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时07分，雷克兰医疗工业股票出现异动，股价急速下挫5.10%。截至发稿，该股报14.79美元/股，成交量2.3689万股，换手率0.25%，振幅7.57%。雷克兰医疗工业股票所在的服装制造行业中，整体跌幅为1.12%。雷克兰医疗工业公司简介：美国雷克兰工业公司为工业防护服市场制造和销售安全服装和配件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042123074394dcfff6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042123074394dcfff6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0031619046.USD","BK4568","BK4202","IE00B66KJ199.SGD","IE00B19Z4B17.USD","IE00B7SZL793.SGD","LAKE"],"gpt_icon":0},{"id":"2529831773","title":"Biontech Se涨1.26% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2529831773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529831773?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:08","pubTimestamp":1745244487,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时08分，Biontech Se股票出现波动，股价快速上涨1.26%。截至发稿，该股报100.00美元/股，成交量8.7354万股，换手率0.04%，振幅2.69%。Biontech Se股票所在的生物技术行业中，整体跌幅为0.23%。Biontech Se公司简介：BioNTech是一家总部位于德国的生物技术公司，专注于开发癌症治疗药物，包括个体化免疫疗法，以及包括冠状病毒在内的传染病疫苗。BioNTech与几家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和Genmab。冠状病毒疫苗是其首个商业化产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220807aa2c7433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220807aa2c7433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4551","BNTX","BK4568","BK4535","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2529800219","title":"伊诺维奥制药盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529800219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529800219?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:07","pubTimestamp":1745244449,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时07分，伊诺维奥制药股票出现波动，股价快速拉升5.17%。截至发稿，该股报1.83美元/股，成交量4.8033万股，换手率0.13%，振幅4.31%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体跌幅为0.34%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。该公司专注于开发和商业化 DNA 药物，以帮助治疗和保护人们免受 HPV 相关疾病、癌症和传染病的侵害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220730a46127bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220730a46127bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4139","BK4583","BK4568"],"gpt_icon":0},{"id":"2529807663","title":"Ibio, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529807663?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 21:58","pubTimestamp":1745243915,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时58分，Ibio, Inc.股票出现异动，股价急速下挫5.03%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Dogwood Therapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为887.14%、459.86%、209.81%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Aptevo Therapeutics Inc.，振幅分别为52.95%、43.24%、23.20%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042121583694dcf169&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042121583694dcf169&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"gpt_icon":0},{"id":"2529076528","title":"莫德纳盘中异动 早盘股价大跌5.04%报23.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529076528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529076528?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 21:33","pubTimestamp":1745242380,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时33分，莫德纳股票出现波动，股价快速下挫5.04%。截至发稿，该股报23.47美元/股，成交量48.5827万股，换手率0.13%，振幅2.06%。莫德纳股票所在的生物技术行业中，整体跌幅为0.66%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213301973f727b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213301973f727b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","BK4534","BK4551","BK4588","BK4501","BK4533","BK4548","MRNA","BK4585","BK4532"],"gpt_icon":0},{"id":"2529760805","title":"吉利德科学(GILD.O)宣布Trodelvy（戈沙妥珠单抗）联合Keytruda（帕博利珠单抗）在第三级临床试验中达到","url":"https://stock-news.laohu8.com/highlight/detail?id=2529760805","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529760805?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 20:34","pubTimestamp":1745238866,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BJT1NW94.SGD","03347","LU1934455194.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","LU1989772923.USD","LU1917777945.USD","BK4585","LU1989771016.USD","LU1116320737.USD","MRK","LU0320765646.SGD","LU1066051811.HKD","LU1116320901.HKD","SG9999014542.SGD","LU1162221912.USD","BK4588","LU1571399168.USD","LU0965508806.USD","LU2361045086.USD","LU1093756168.USD","BK4568","LU1430594728.SGD","LU1585245621.USD","SG9999015341.SGD","LU0203345920.USD","BK4533","SG9999014567.USD","IE00BBT3K403.USD","BK4559","LU1291159041.SGD","GILD","BK1583","LU0238689110.USD","LU2106854487.HKD","IE0009355771.USD","LU0211331839.USD","LU1066051498.USD","SG9999002224.SGD","LU0965509101.SGD","BK4532","LU0965509283.SGD","LU2361044949.HKD","LU0070302665.USD","LU2461242641.AUD","SG9999015358.SGD","LU1069347547.HKD","LU2361044865.SGD","SGXZ57979304.SGD","LU0122379950.USD"],"gpt_icon":0},{"id":"2529287439","title":"古根海姆：将强生(JNJ.N)目标价从166美元下调至164美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529287439","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529287439?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 18:58","pubTimestamp":1745233131,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0234570918.USD","LU0320765646.SGD","IE00BDGV0183.EUR","LU0795875169.SGD","LU2112291526.USD","LU2129689514.USD","LU1914381329.SGD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU1732800096.USD","IE00B3T34201.USD","LU0114720955.EUR","LU1032955483.USD","IE00BVYPNV92.GBP","BK4592","BK4534","BK4568","JNJ","BK4588","LU1059921491.USD","LU2430703178.SGD","IE00B19Z3581.USD","SG9999002232.USD","LU0203345920.USD","LU0234572021.USD","BK4504","LU1221951046.USD","LU1244550221.USD","SG9999002224.SGD","IE00BSNM7G36.USD","IE000M9KFDE8.USD","IE00BJJMRZ35.SGD","LU2133065610.SGD","IE00B4R5TH58.HKD","BK4585","BK4533","LU1506573853.SGD","IE00B19Z3B42.SGD","LU1935042991.SGD","LU1023059063.AUD","LU0889566641.SGD","LU1061106388.HKD","IE00B7SZLL34.SGD","LU2129689605.HKD","IE00BLSP4239.USD","LU0203347892.USD","LU2505996509.AUD","LU1074936037.SGD","LU2468319806.SGD","LU1280957306.USD"],"gpt_icon":0},{"id":"2529230888","title":"十年来首个，第一三共/阿斯利康“德曲妥珠单抗”III期中期分析取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2529230888","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529230888?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 15:03","pubTimestamp":1745218980,"startTime":"0","endTime":"0","summary":"阿斯利康和第一三共的德曲妥珠单抗（Enhertu）在III期临床试验中显示，联合帕妥珠单抗一线治疗HER2阳性转移性乳腺癌，相比标准治疗显著改善无进展生存期，且总生存期早期趋势更优。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421155116973f2166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421155116973f2166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","III","BK4134","BK4588","LU2417539215.USD","LU0109394709.USD","LU1829250122.USD","LU2456880835.USD","AZN","LU0889565916.HKD","LU2462157665.USD","LU2236285917.USD","BK4007","LU0320765992.SGD","BK4585"],"gpt_icon":0},{"id":"2528583159","title":"已提交现货ETF申请的山寨币均为“美国币”或属于WLFI投资组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2528583159","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528583159?lang=zh_cn&edition=fundamental","pubTime":"2025-04-20 10:59","pubTimestamp":1745117963,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/ai_9684xtpa/status/1913783069582213172","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4086","BK4228","APT.USD.CC","AVAX.USD.HKCC","SUI","BK4568","SOL.USD.HKCC","BK4129","BK4519","BK4550","LTC","BK4225","APT","BK4203","BK4170","FDN","MOVE","BK4017","BK4588","TRX","SOL","AVAX.USD.CC","APT.USD.HKCC","BK4215","BK4585","LTC.USD.HKCC"],"gpt_icon":0},{"id":"2528704162","title":"Aptos社区提案拟将质押年化收益下调近50%以提升资本效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2528704162","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528704162?lang=zh_cn&edition=fundamental","pubTime":"2025-04-19 08:26","pubTimestamp":1745022376,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 Aptos 社区成员 MoonSheisty 于 4 月 18 日提交提案，建议将 APT 代币质押年化收益率从 7%逐步下调至 3.79%，以期在三个月内提高资本效率，并与其他 L1 区块链保持一致。该提案引发社区关注，部分成员担忧此举或削弱小型验证者参与度，影响去中心化水平。（Cointelegraph）\n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/427666?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["APT","APT.USD.HKCC","BK4568","BK4086","APT.USD.CC"],"gpt_icon":0},{"id":"2528479470","title":"近90%患者缓解的强生口服多肽疗法；默沙东达近5亿美元口服多肽疗法合作 TIDES周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2528479470","media":"动脉网","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528479470?lang=zh_cn&edition=fundamental","pubTime":"2025-04-19 07:41","pubTimestamp":1745019660,"startTime":"0","endTime":"0","summary":"强生口服多肽疗法3期临床试验结果积极，近90%的青少年患者皮肤症状清除。默沙东与Cyprumed合作开发口服多肽药物。TIDES疗法领域迎来系列进展，包括其他多肽疗法的临床试验结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419093620973d2c02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419093620973d2c02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1732799900.SGD","LU1066051225.USD","IE00B1BXHZ80.USD","LU1023059063.AUD","IE00BVYPNV92.GBP","LU0058720904.USD","SG9999002224.SGD","LU0238689110.USD","LU0320765646.SGD","SG9999002232.USD","SG9999014542.SGD","JNJ","BK4534","IE00BFTCPJ56.SGD","LU1894683348.USD","LU2129689605.HKD","LU1267930813.SGD","IE00B19Z3B42.SGD","IE0002141913.USD","LU1291159041.SGD","LU0640476718.USD","SG9999014575.USD","LU0203345920.USD","LU1066051498.USD","MRK","IE00BLSP4452.SGD","LU0208291251.USD","LU2129689431.USD","IE00B2B36J28.USD","LU2129689514.USD","LU0792757196.USD","BK4532","IE00BVYPNW00.USD","LU2430703251.USD","LU1430594728.SGD","LU0795875086.SGD","LU1585245621.USD","LU0795875169.SGD","LU1221951129.SGD","LU0006306889.USD","LU1934455863.HKD","BK4568","IE00BN8TJ469.HKD","LU1196500208.SGD","LU1244550494.USD","LU0345769631.USD","IE00B4R5TH58.HKD","LU2324357040.USD","LU0203347892.USD","LU1035773651.USD"],"gpt_icon":0},{"id":"2528109676","title":"Aptos社区发起“分阶段降低质押奖励率”提案","url":"https://stock-news.laohu8.com/highlight/detail?id=2528109676","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528109676?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 23:39","pubTimestamp":1744990740,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/290327","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["APT.USD.CC","BK4086","APT.USD.HKCC","AIP","BK4097","APT","BK4568"],"gpt_icon":0},{"id":"2528061776","title":"阿斯利康(AZN.US)乳腺癌1类创新药在中国获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2528061776","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528061776?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 21:14","pubTimestamp":1744982042,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月18日，中国国家药监局官网最新公示，批准阿斯利康的1类创新药卡匹色替片上市。该产品已于2023年11月获美国FDA批准上市，用于治疗激素受体阳性、人表皮生长因子受体2阴性的晚期或转移性乳腺癌成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1574","LU0109394709.USD","LU0320765992.SGD","LU2456880835.USD","06978","159992","BK1161","LU2236285917.USD","LU0889565916.HKD","LU2462157665.USD","LU2417539215.USD","BK4585","BK4568","LU1829250122.USD","BK4007","AZN"],"gpt_icon":0},{"id":"2528063324","title":"辉瑞：已计入风险，买入具有卓越估值和收益的股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2528063324","media":"美股研究社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528063324?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 19:39","pubTimestamp":1744976340,"startTime":"0","endTime":"0","summary":"辉瑞管理层并非对股价的熊市视而不见。该公司预计，到2030年，这些药物将成为辉瑞销售额的重大贡献者。总体而言，辉瑞的产品线和战略举措与低迷的市场情绪形成了鲜明对比。辉瑞目前的市值约为1250亿美元，约为其2024年销售额630亿美元的两倍。因此，鉴于其极具吸引力的7倍市盈率和卓越的股息收益率，分析师首次评级为“强力买入”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-04-18/doc-inetquyn4701364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BBT3K403.USD","IE00B19Z3581.USD","LU0225771236.USD","LU0321505439.SGD","SG9999002232.USD","BK4568","BK4581","BK4007","LU1894683264.USD","LU0122379950.USD","LU1883839398.USD","SG9999001176.USD","LU0306807586.USD","SG9999001176.SGD","SGXZ57979304.SGD","BK4534","BK4588","LU0234572021.USD","PFE","BK4550","LU0170899867.USD","SG9999003800.SGD","LU0058720904.USD","LU0289739699.SGD","SG9999013999.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","BK4585","SG9999011175.SGD","LU0306806265.USD","LU1066051498.USD","LU1894683348.USD","LU0321505868.SGD","LU0225284248.USD","LU1066053197.SGD","IE00BLSP4239.USD","IE0002270589.USD","SG9999002224.SGD","LU0868494617.USD","BK4599","LU0456855351.SGD","LU0985481810.HKD","LU1057294990.SGD","BK4533","IE00BLSP4452.SGD","BK4592"],"gpt_icon":1},{"id":"2528681880","title":"【沃森生物：20价肺炎球菌多糖结合疫苗获临床试验批准】沃森生物公告，公司及子公司共同申请的20价肺炎球菌多糖结合疫苗获得国家药品监督管理局签发的《药物临床试验批准通知书》，通知书编号为2025LP01099。该疫苗是在已上市产品13价肺炎球菌多糖结合疫苗基础上开发的迭代升级产品，新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共计7种血清型，用于预防由本品所含20种肺炎球菌血清型引起的感染性疾病。全球已上市20价肺炎球菌多糖结合疫苗的厂家仅有美国辉瑞公司一家，国内尚未有20价肺炎球菌多糖结合疫苗上市销售。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528681880","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528681880?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 19:21","pubTimestamp":1744975312,"startTime":"0","endTime":"0","summary":"沃森生物公告，公司及子公司共同申请的20价肺炎球菌多糖结合疫苗获得国家药品监督管理局签发的《药物临床试验批准通知书》，通知书编号为2025LP01099。该疫苗是在已上市产品13价肺炎球菌多糖结合疫苗基础上开发的迭代升级产品，新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共计7种血清型，用于预防由本品所含20种肺炎球菌血清型引起的感染性疾病。全球已上市20价肺炎球菌多糖结合疫苗的厂家仅有美国辉瑞公司一家，国内尚未有20价肺炎球菌多糖结合疫苗上市销售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18192149669574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0306806265.USD","300142","IE0002270589.USD","IE000M9KFDE8.USD","BK0239","BK4533","LU0456855351.SGD","LU1066051498.USD","BK4581","LU1023059063.AUD","IE00BLSP4452.SGD","BK4007","IE00BBT3K403.USD","LU1057294990.SGD","BK1141","LU0321505439.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","LU0225771236.USD","BK1576","BK4585","SG9999013999.USD","LU1894683348.USD","LU1894683264.USD","SG9999002224.SGD","03347","BK4534","BK0070","BK4568","IE00BLSP4239.USD","LU0225284248.USD","159646","LU1883839398.USD","BK4599","BK0077","LU0985481810.HKD","SG9999003800.SGD","LU0170899867.USD","SG9999011175.SGD","LU0234572021.USD","BK4592","LU0058720904.USD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999002232.USD","SG9999001176.USD","LU0306807586.USD","SG9999001176.SGD"],"gpt_icon":0},{"id":"2528886930","title":"辉瑞4月17日成交额为12.06亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528886930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528886930?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 10:20","pubTimestamp":1744942854,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，辉瑞成交额为12.06亿美元，成交额较昨日增加44.24%，当日成交量为5407.37万股。辉瑞于2025年4月17日涨0.45%，报22.14美元，该股过去5个交易日涨2.55%，年初至今跌15.16%，过去60日跌13.47%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-17|12.06亿|44.24%|5407.37万|#|2025-04-16|8.36亿|-28.41%|3764.12万|#|2025-04-15|11.68亿|-14.48%|5181.47万|#|2025-04-14|13.66亿|14.34%|6190.09万|#|2025-04-11|11.95亿|-24.16%|5507.81万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418102055a6beb6ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418102055a6beb6ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002232.USD","LU0321505868.SGD","LU1023059063.AUD","PFE","BK4585","BK4534","LU1057294990.SGD","SG9999002224.SGD","BK4007","LU0058720904.USD","BK4581","LU0868494617.USD","LU0306807586.USD","SG9999011175.SGD","BK4568","LU1066051498.USD","LU0456855351.SGD","BK4533","SG9999003800.SGD","LU0321505439.SGD","BK4599","LU0122379950.USD","LU1894683348.USD","LU0225771236.USD","BK4550","LU0306806265.USD","BK4592","SG9999013999.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU0289739699.SGD","LU1894683264.USD","LU0170899867.USD","LU1066053197.SGD","LU0985481810.HKD","SG9999001176.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","IE0002270589.USD","LU1883839398.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0234572021.USD","BK4588","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2528088636","title":"强生心血管业务发力了","url":"https://stock-news.laohu8.com/highlight/detail?id=2528088636","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528088636?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 10:15","pubTimestamp":1744942500,"startTime":"0","endTime":"0","summary":"强生发布2025年一季度财报，显示其总营收达219亿美元，同比增长2.4%，净利润为110亿美元，同比暴涨237.91%。其中，心血管业务表现尤为突出，销售额达到21亿美元，同比上涨16.4%，占总营收的26%。尽管骨科、外科和眼科等其他业务板块也有所增长，但增速相对缓慢。特别是在骨科领域，强生医疗正通过重组DePuy Synthes业务以应对市场挑战。此外，强生在心血管领域的重金布局也显现出成效，近年来已斥资超过300亿美元进行多次收购，进一步巩固了其在该领域的领先地位。然而，关税问题预计将在全年带来约4亿美元的额外成本，主要影响医疗技术板块。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041810181294d97f87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041810181294d97f87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2430703178.SGD","IE00BJT1NW94.SGD","LU0985320562.USD","LU1066053197.SGD","LU1585245621.USD","LU2430703095.HKD","BK4568","IE00B19Z3B42.SGD","LU1061106388.HKD","JNJ","LU1059921491.USD","LU2129689605.HKD","BK4581","LU0792757196.USD","LU0345769631.USD","SG9999001440.SGD","BK4588","LU1221951129.SGD","LU0203345920.USD","IE00BLSP4239.USD","LU0203347892.USD","LU1267930813.SGD","LU2129689514.USD","IE00BLSP4452.SGD","LU2133065610.SGD","LU0345770308.USD","LU1074936037.SGD","LU2347655156.SGD","LU1280957306.USD","LU2602419157.SGD","LU0345769128.USD","LU2129689431.USD","IE0002141913.USD","LU2468319806.SGD","BK4533","LU0289739699.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00B1BXHZ80.USD","LU1244550577.SGD","LU2089984988.USD","IE00BN8TJ469.HKD","LU1221951046.USD","LU2505996681.GBP","LU0466842654.USD","LU1914381329.SGD","LU1196500208.SGD","LU0098860793.USD","LU0795875086.SGD","LU1732800096.USD"],"gpt_icon":0},{"id":"2528886390","title":"莫德纳4月17日成交额为1.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528886390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528886390?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 10:04","pubTimestamp":1744941850,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，莫德纳成交额为1.65亿美元，成交额较昨日增加19.37%，当日成交量为668.50万股。莫德纳于2025年4月17日跌1.89%，报24.72美元，该股过去5个交易日涨0.88%，年初至今跌40.56%，过去60日跌35.81%。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100413a6beb234&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100413a6beb234&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4585","BK4501","MRNA","BK4551","BK4139","BK4533","BK4548","BK4568","BK4532","BK4588"],"gpt_icon":0},{"id":"2528370093","title":"强生4月17日成交额为17.30亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528370093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528370093?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 09:47","pubTimestamp":1744940856,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，强生成交额为17.30亿美元，成交额较昨日增加40.68%，当日成交量为1098.11万股。强生于2025年4月17日涨2.31%，报157.47美元，该股过去5个交易日涨5.9%，年初至今涨9.75%，过去60日涨9.26%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-17|17.30亿|40.68%|1098.11万|#|2025-04-16|12.29亿|-26.24%|798.73万|#|2025-04-15|16.67亿|1.46%|1084.77万|#|2025-04-14|16.43亿|9.53%|1068.53万|#|2025-04-11|15.00亿|-26.76%|994.39万|强生公司是世界上最大的、最多元化的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418094743a45d44a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418094743a45d44a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU0889566641.SGD","IE00BBT3K403.USD","IE00B4R5TH58.HKD","LU1894683348.USD","LU2089984988.USD","LU1261432733.SGD","IE00BJT1NW94.SGD","JNJ","IE0034235303.USD","LU1778281490.HKD","LU0345769631.USD","LU0203347892.USD","LU1585245621.USD","BK4504","LU1066051225.USD","LU2505996681.GBP","LU2112291526.USD","LU1032466523.USD","LU0345770308.USD","LU0882574055.USD","BK4007","LU0912757837.SGD","SG9999002232.USD","LU1718418525.SGD","IE0002141913.USD","LU0234570918.USD","LU0098860793.USD","LU1244550494.USD","BK4550","BK4568","LU1894683264.USD","BK4592","IE00BDGV0183.EUR","LU0640476718.USD","LU1732799900.SGD","LU2505996509.AUD","BK4585","LU0203345920.USD","LU1162221912.USD","LU1244550577.SGD","LU0234572021.USD","LU2602419157.SGD","IE0009355771.USD","LU0289739699.SGD","LU2592432038.USD","LU2129689431.USD","BK4581","LU1221951046.USD","LU1196500208.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":181,"code":"91000000","status":"200"}]}}